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Background: In Germany, patients severely affected by Multiple Sclerosis (MS) do not routinely come into contact
with palliative care, even if possibly beneficial. This study was aimed at investigating how severely affected MS
patients and their health professionals perceive palliative care to determine how to better approach these patients
in Germany about this topic.
Methods: 15 patients feeling severely affected by MS and 23 health professionals experienced with MS patients
(3 social workers, 7 nurses, and 13 physicians) in both in-/outpatient and rural/ urban settings participated in this
qualitative study in Germany. Semi-structured interviews (patients, health professionals) and focus groups (health
professionals) were conducted, transcribed verbatim and analyzed via qualitative content analysis.
Results: MS patients were mostly unfamiliar with the term “palliative care” or were aware of it only in relation to
cancer and dying. They did not view it as relevant to themselves. Health professionals predominantly associated
palliative care with dying cancer patients, if familiar with it at all. Most physicians doubted its relevance for neurological
patients and denied MS as a cause of death. Nevertheless, most felt they already offered their patients sufficient palliative
care, or thought that it could not meet MS patients’ complex needs. Most nurses and social workers recognized deficits in
existing care structures and regarded palliative care as an opportunity for MS patients.
Conclusion: MS patients’, and health professionals’ restricted, death-associated awareness of palliative care leads to
discomfort, fear or rejection of this idea. Therefore, a defined concept of palliative care emphasizing opportunities for
severely affected MS patients and considering early integration should be spread throughout the German MS community
as an additional layer of support for this patient group.
Keywords: Attitudes towards palliative care, Health professionals, Severely affected multiple sclerosis patients,
Palliative care, Multiple sclerosisBackground
Despite clear advances in research and treatment [1]
Multiple Sclerosis (MS) remains a chronic, inflammatory,
incurable disease of the central nervous system. Chronic
progressive MS develops among 30-40% of patients within
10 to 15 years after diagnosis, with a significant proportion
of patients having to cope with severe physical disability
as well as psychological implications [2-4]. Approximately
half of all MS patients die from MS itself or related* Correspondence: heidrun.golla@uk-koeln.de
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unless otherwise stated.complications, including accidents, severe falls, and sui-
cide, evincing a culmination of severe psychological prob-
lems; approximately another third die from cardiac and
vascular disease, cancer, infectious and respiratory diseases
[5-7]. MS patients’ level of suffering from their “burden
of symptoms” is comparable with that of palliative can-
cer patients [8], and MS patients and health profes-
sionals identify complex unmet needs which might be
met by palliative care services [9-15]. Therefore, neuro-
rehabilitation and palliation must play an important role
in the management of MS patients beyond disease modi-
fying treatments [2,11-14,16,17]. Presently, however, MS
patients in Germany do not routinely come into contactd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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eral providers nor via specialized palliative care services
and institutions. This is possibly because it appears to be
counterintuitive to many providers, in contrast to the UK’s
pioneering role in implementing palliative care also for pa-
tients with neurological long term conditions [11-14,18-20].
Concepts designed to bring the palliative care approach
to Germany’s MS patients must take into consideration
the attitudes of both patients and associated health profes-
sionals. This qualitative study aimed to investigate how se-
verely affected MS patients and health professionals in
Germany understand palliative care, what they associate
with this approach and if, or how, they feel palliative care
might help these patients.
Methods
Design
Qualitative study of face-to-face cross-sectional, semi-
structured interviews and focus groups with patients
and health professionals analyzed via qualitative content
analysis.
Context and sample
Patients and health professionals were selected using a mix
of purposeful and convenience strategies; this was done
within a larger study frame on ‘unmet needs of severely af-
fected MS patients’ in Germany [10,15]. All participants
provided informed written consent. The Committee for
Medical Research Ethics of the University of Cologne ap-
proved the study (IRB approval #06-191).
Health professionals
Physicians, nurses and social workers from a rural clinic
specialized in MS and from 3 city neurology wards received
invitations to participate in the study via post, email or tele-
phone. An additional 60 Cologne city neurologists working
in private practice and 88 GPs were contacted by mail. Ul-
timately 13 physicians, 7 nurses and 3 social workers agreed
to participate in the study. Reasons for refusal cited lack of
time, lack of remuneration for study participation or simply
inexperience with MS [10].
Patients
A population of MS patients who reported feeling severely
affected by their disease was recruited for this study.
Health professionals in Cologne, Germany and surround-
ing areas (GPs, in- and outpatient neurologists, nurses,
MS clinic team, city/rural area) were asked to help recruit
MS patients by distributing leaflets about the study and by
querying patients directly during visits to their doctor. For
her interviews MG discussed participation with clinic pa-
tients during rounds. Of 22 patients approached for the
study, 15 agreed to take part. Reasons for refusal were not
assessed [15].Data collection
Health professionals
Semi-structured interviews were conducted with health
professionals (2 social workers, 2 GPs, 5 neurologists),
while others participated in a focus group (first group: 2
nurses and 1 social worker; second group: 6 neurologists
in private practice; third group: 5 nurses). Interviews and
focus groups were both conducted at the Department of
Palliative medicine (University Hospital of Cologne) or at
participants’ working place and lasted 30 - 90minutes (HG,
MG). Socio-demographic information was recorded using
a questionnaire completed by all health professionals fol-
lowing the interview/focus group [10].
Patients
Semi-structured face-to-face interviews (25 - 120 minutes)
were conducted by MG at patients’ homes (4 patients) or
on neurology wards (11 patients; short-term inpatient care,
1 of whom was normally in long-term nursing home care).
Patients who so desired were allowed to have a relative
present during their interview (5 instances). Each patient’s
disease-specific information was collected via a short ques-
tionnaire including the EDSS (Expanded Disability Status
Scale) [21] and a self-developed, non-validated scale (1-10)
for rating the extent of feeling severely affected (“How
severely affected are you?”, where 1 = not at all and 10 =
totally severely affected) [15].
Our study emerged from efforts to understand the
broader topic of unmet needs of severely affected MS pa-
tients in Germany which was investigated by using a mixed
method design [10,15,22]. In this greater study frame on
unmet needs of severely affected MS patients, pilot-tested
interview guidelines for the different stakeholders were first
developed in the qualitative study phase. Interviews and
focus groups provided an opportunity to ask questions ac-
cording to interview guidelines about unmet needs, feeling
severely affected by MS and about palliative care [10,15].
The question of how severely affected MS patients and in-
volved health professionals understand palliative care was
singled out for this study, while we also hoped to discern
what they associate with this approach and if, or how, they
feel palliative care might help these patients. So, for the re-
sults presented here only those questions of the interview
guidelines asking about participants’ associations with, and
attitudes towards palliative care/hospice were relevant. Ex-
amples of questions on this topic for health professionals
were: “In your view, what does palliative care/hospice
mean? Under which conditions could you imagine using
palliative care services for your MS patients?” and for pa-
tients: “What ideas do you have about palliative care/hos-
pice? Under which conditions can you imagine to use
palliative care services for yourself?” No definition of pallia-
tive care was offered to interviewees as we were interested
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palliative care in general and in context with MS patients.
Investigators’ basic definition for the concept of palliative
care conforms to the 2002 WHO statement:
“Palliative care is an approach that improves the quality
of life of patients and their families facing the problem as-
sociated with life-threatening illness, through the preven-
tion and relief of suffering by means of early identification
and impeccable assessment and treatment of pain and
other problems, physical, psychosocial and spiritual” [23].
All investigators were well informed and up-to-date re-
garding the developing structures of palliative care, both
general and specialized, in Germany.
Audio recordings were made of the semi-structured
interviews and focus groups, and then transcribed verba-
tim; these were not returned to participants. Field notes
were also made (HG, MG). MG (sociologist) and HG
(MD) worked as researchers at the Department of Palliative
medicine and were experienced in interviewing palliative
care (MG, HG) and neurological (HG) patients as well as
health professionals (MG).
Analysis
Interviews and focus groups were first analyzed for evolv-
ing categories of unmet needs as previously described
[10,15]. This paper concentrates on the analysis of attitudes
towards palliative care held by health professionals and se-
verely affected MS patients:
All transcripts of interviews and focus groups were
separately, inductively coded with open codes by one of
the interviewers. Thematic units concerning attitudes to-
wards palliative care were analyzed and categorized using
the method of constant comparison (HG, MG). MG veri-
fied evolving categories and issues found by HG and vice
versa. The raw data and related codes were then multi-
professionally discussed amongst all authors (HG, MG, HP,
RV) [24]. Respondents’ implicit views were then included
into the coding process. The constant comparison of the
codes for explicit and implicit views of all cases (focus
groups and interviews) were searched for minimal/maximal
contrasts (HG, MG) [25,26]. This comparison resulted in
ongoing refinement from first codes to preliminary categor-
ies and then to categories on a higher abstraction level that
could be applied to all data. MG checked the coding
process and plausibility of evolving preliminary categories
found by HG, and vice versa. For focus groups we also con-
sidered the group interaction and the sequence of topics
[27-29]. This study conforms to COREQ guidelines for
reporting qualitative research [30].
Results
Sample
Characteristics of the samples are summarized in Tables 1
and 2.Categories
According to findings of this study, associations with
palliative care by severely affected MS patients and health
professionals caring for such patients can be classified into
four main categories: ‘uncertain knowledge’, ‘life limita-
tion’, ‘excess’ and ‘chance’ all of which could be further di-
vided into subcategories (Figure 1).
Figure 2A-D depicts an itemization for the different
stakeholders’ attitudes (patients, nurses, social workers and
physicians); followed by a detailed description of each
stakeholder group’s view below.
MS patients
Figure 2A summarizes the categories of patients’ associa-
tions with palliative care. Two interviews were prema-
turely terminated due to patient exhaustion.
Main category uncertain knowledge
Of the remaining 13 patients, six had no idea what pal-
liative care meant (“foreign word”) (subcategory no idea)
and seven patients had a rather vague notion (subcat-
egory speculations): One patient speculated that pallia-
tive care meant “acute treatment of cancer patients”; for
another it was support for chronically ill patients, while
others guessed that it was “alternative”, “traditional”, or
“ancient” medicine. Patients interviewed had heard of hos-
pice slightly more often than palliative care, but could not
differentiate between the terms or were rather uncertain
in this regard. While some patients thought hospice was a
hospital, others wondered whether adequate medical care
was guaranteed there at all, and one patient thought that
access to hospice would be difficult.
Main category life limitation
Those who had heard of palliative care mainly regarded
it in the context of hospice, critical illness and especially
cancer (subcategory cancer), or dying (subcategory death
and dying), and characterized it as terminal care or as
help to die (subcategory terminal care). Patients could
not imagine palliative care for themselves. They felt this
approach would come too early in their life or they
could not associate it with MS and their own situation
at all.
If I was really seriously ill and and really unable to do
absolutely anything alone, then I would consider this.
[…] However, otherwise […] whether this absolutely
has to be, to think, about this now already […] when
someone is incurably ill with cancer, for example, then
that is the time for palliative care that is essentially …
end of life care […]
Interview with patient, secondary progressive MS
(IntGa1 ll. 1593-1612)











Relapsing-remitting (5) Female (3) Range: 34 - 54 Range: 5 - 8 Range: 5 – 6,5 Married (4) Full-time working (2)
Male (2) Mean: 40,4 Mean: 6,6 Mean: 6 Unmarried (1) Retired (2)
(1 Unknown) Unemployed (1)
Primary progressive (4) Female (2) Range: 23 - 73 Range: 6 - 10 Range: 3 - 9 Married (2) Full-time working (1)
Male (2) Mean: 55 Mean: 7,3 Mean: 6,4 Unmarried (1) Retired (3)
Widowed (1)
Secondary progressive (3) Female (2) Range: 39 - 56 Range: 6 - 8 Range: 6 - 8 Married (2) Full-time working (1)
Male (1) Mean: 45 Mean: 7,3 Mean: 7 Unmarried (1) Retired (2)
Unknown (3) Female (3) Range: 40 - 55 Range: 4 - 10 Range: 6,5 – 8,5 Married (1) Retired (3)
Mean: 49,7 Mean: 6 Mean: 7,5 Unmarried (1)
(1 Unknown) Divorced (1)
*To guarantee anonymity, we use the male form only in the text.
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in a hospice as a helpless life no longer worth living
(subcategory deterrence).
[…] Hospice is actually terrifying […] linked for me
with being absolutely helpless, the last step, and
actually just vegetating […] keep it at a distance. Best
not to experience this.
Interview with patient, relapsing-remitting MS (Intga8
ll. 1069-1086)
Main category chance
In the context of terminal care for cancer patients, MS
patients principally thought of palliative care as a positive
approach. Palliative care or hospice was predominately
well-respected. The expressed view was that it stands for
qualified care for dying cancer patients encompassing pain
treatment and support for both the dying and their rela-
tives (subcategory qualified care).
Health professionals – Nurses
Figure 2B summarizes the categories of nurses’ associa-
tions with palliative care.
Main category uncertain knowledge
Three of the seven participating nurses (Table 2) had no
idea of what palliative care was; two of these individuals
work with MS outpatients and one with MS patients in
a specialized MS clinic (subcategory no idea). The other
four who work in a specialized MS clinic had vague (e.g.
“alternative” medicine) and limited ideas of palliative care;
making associations such as company, palliation and sup-
port (subcategory speculations). They confused the terms
palliative care and hospice. The nurses knew of theexistence of hospice services but had difficulty imagin-
ing their tasks.
Main category life limitation
Hospice and palliative care were linked with “last stop”
and “final situation” (subcategory death and dying). It
was appreciated as dignified terminal care (“kind dying”)
(subcategory terminal care) especially for dying cancer
patients (subcategory cancer).
Main category chance
Palliative care was principally linked with qualified care
and the interviewed nurses thought that such care would
also be worthwhile for severely affected MS patients
(subcategory qualified care). Moreover, the nurses have
made the experience that nursing homes are not pre-
pared for the complex needs of MS patients, leading to
care deficits. They had the expectation that the palliative
approach could offer a better alternative (subcategory
better structures). In particular, they hoped that palliative
care could offer MS patients a continuous contact person
who accompanies, offers answers to questions and points
out new opportunities (subcategory continuity of care).
Health professionals - Social Workers
Figure 2C summarizes the categories of social workers’
associations with palliative care.
The three social workers (Table 2) disagreed on whether,
how and to what degree palliative care should be available
for MS patients.
Main category life limitation
The social worker at a specialized MS clinic thus far knew
palliative care only in connection with cancer patients
(subcategory cancer) but held the view that MS patients
could also benefit from it. The palliative care unit social
Table 2 Characteristics of health professionals interviewed
Profession (Number
in brackets)
Working place (Number in brackets) Participation in Professional
experience [years]
Experience with MS [years] Gender *
(Number in brackets)
Age [years]
Nurses (7) MS outpatients (2) First focus group Range: 15 - 28 Range: 0,5 - 20 Female (6) Range: 35 - 57
Specialized MS clinic, inpatient (5) Third focus group Mean: 23 (1 Missing data) Mean: 11,4 Male (1) Mean: 46
Social workers (3) Clinic for neurology and psychiatry (1) First focus group Range: 28 - 30 Range: 10 - 30 Female (2) Range: 47 - 52
Specialized MS clinic (1) Interview Mean: 29 Mean: 22,3 Male (1) Mean: 49,3
Palliative care unit (1) Interview
Physicians (13) Neurologists in own practice (6) Second focus group Range: 6,5 – 30 Range: 6,5 – 30 Female (5) Range: 35 - 59
General practitioners in own practice
(2), one of them additionally nursing home doctor
With each interview Mean: 18,7 (1 Missing data) Mean: 16,9 Male (8) Mean: 46,8
(1 Missing data)
Clinic neurologists With each interview
- Specialized MS clinic (2)
- General neurology clinic (3)














































Figure 1 Associations with palliative care (PC) for MS: System of categories evolving from all stakeholders, MS patients as well as
health professionals.
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spective of diagnosis but recognized that it was primarily
offered to dying cancer patients (subcategory cancer, sub-
category death and dying). The neurology/psychiatry so-

































Figure 2 Associations with palliative care (PC) for MS: System of cate
workers (n = 3) and D Physicians (n = 13); dashed lines in all boxes (A
or vague ideas of palliative care; C Social workers agree that palliativ
D Physicians concentrate on palliative care as qualified care for termifor cancer patients (subcategory cancer). His view was that
cancer palliation should start once tumor therapy had
been exhausted (subcategory end of disease modification),
and a place for dying should be organized (subcategory





































gories evolving from A Patients (n = 13), B Nurses (n = 7), C Social
-D) for a special focus: A Patients and B Nurses mostly have no,
e care offers qualified care for terminally ill cancer patients;
nally ill cancer patients.
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of death and dying (subcategory terminal care).
Main category excess
The neurology/psychiatry social worker was convinced
that with sufficient advance planning MS patients would
not need palliative care. He regarded nursing homes as
appropriate institutions for MS patients only if these
possess the requisite knowledge and experience with MS
patients. His opinion was that this is the most decisive
factor as to whether MS patients would receive appro-
priate care, and that having additional knowledge about
palliative care would not improve MS patients’ care in
his view. He also expressed the view that palliative care
units could not offer more to MS patients than good
neurological units, as such neurological units are spe-
cialized in care for MS patients and thus possess suffi-
cient knowledge required to meet MS patients’ concerns
(subcategory sufficient structures). The main arguments
against palliative care for MS patients, in his view, were
the long-lasting and unclear disease trajectory, and that
as he understood it, the typical burdensome symptoms
of MS patients could not be palliated as effectively as
the pain of cancer patients, for example.
These chronic illnesses go on a long time, many years,
so I wouldn’t necessarily see palliative care as sensible,
[…] I can’t see any real sense behind this. […] apart
from, maybe, from a temporary respite […] so I, for me,
that is rather more an excess of care I would say.
Social worker, clinic for neurology and psychiatry, focus
group of nurses and social worker (fg1ga ll. 1739-1757)
Main category chance
The specialized MS clinic social worker regarded palliative
care as a worthwhile opportunity also for MS patients: He
expected palliative care to offer pain management (sub-
category pain management); individual, intensive, per-
haps even one-on-one care which considered everyday
life wishes, support in accepting MS as well as prepar-
ation for dying (subcategory qualified care). He stressed
the potential financial opportunities which may open to
support MS patients should they be considered for pal-
liative care and special funding as are cancer patients
(subcategory financial opportunity). He presumed the
necessity for long-lasting continuous support because of
the lengthy, unpredictable disease trajectory (subcat-
egory continuity of care).
And when […] palliative care makes it possible to
have access to other resources, […] financial sources,
and if we could attain this for the most critically ill
MS patients, umm, there where there is no money tomeet the needs, and close the gaps in the care, then
that would also by all means be an important point.
Interview with social worker, specialized MS clinic
(gaso1 ll. 109-128)
The palliative care unit social worker stressed that in his
understanding, independent of diagnosis, the individual pa-
tient’s situation is the decisive factor as to whether palliative
care, in all its forms, with its extensive opportunities, is uti-
lized or not. His opinion was that a stay on a palliative care
unit, for example, could re-energize both the MS patient
and (informal) caregivers, providing the basis for a return
to home care (subcategory better structures). He defined
palliative care as a holistic approach covering medical, nurs-
ing and psychosocial aspects using a multidisciplinary team
who focus on patients’ positive resources even in the face
of death (subcategory better structures).
So I think it’s really important that […] palliative care
[…] is open to all areas of illness. And umm, […] MS
patients with severe symptoms should also have the
opportunity, to have intensive care on the palliative ward
as their illness is incurable, it continues progressing […]
Interview with social worker, palliative care unit
(goso2 ll. 496-503)
Health professionals – Physicians
Figure 2D summarizes the categories of physicians’ asso-
ciations with palliative care.
All 13 physicians queried, independent of specialty,
working place, or position (Table 2) had some idea of
palliative care.
Main category life limitation
Most regarded palliative care as a field of palliation instead
of curing, with predominant or even complete substitution
of etiological treatment. The three general neurology clinic
neurologists, for example, indicated they could envision a
palliative care approach for MS patients once they were no
longer being treated with immunosuppressive or immuno-
modulatory medicines (subcategory end of disease modifica-
tion). Nevertheless, most of the physicians interviewed only
minimally accepted such palliative care approaches for
neurological diseases like MS, if at all, and then in advanced
and terminal cases only (subcategory terminal care).
[…] that there […] could also be palliative care for
persons suffering from MS is perhaps a relatively wild
idea. […] different from, for example, cancer patients,
where one more likely intuitively believes that also
palliative care might make sense, is rather unusual for
those suffering from MS.
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clinic (ar1ga ll. 134-143)
These physicians assessed the disease trajectory of MS
as less clear than that of cancer. They also stated that
MS patients would not die from their disease, regarding
this as the main reason for not pursuing a palliative care
approach with neurological (MS, Parkinson’s etc.) patients.
They emphasized that palliative care was automatically
associated with death and dying (subcategory death and
dying) resulting in both physicians and patients having
reservations (subcategory deterrence). In most cases neu-
rologists would lead their MS patients to believe that their
life expectancy would not be shortened by MS. Particu-
larly neurologists in private practice viewed the main task
of palliative care in managing terminal cases as guarantee-
ing a sort of “kind dying,” at home, if possible (subcategory
terminal care). Such terminal situations were, however,
consistently assumed to be solely in the context of cancer
patients, not neurological patients (subcategory cancer).
[…] generally, as a rule our neurological patients
DON’T die from these neurological disorders - but they
die from other deficits, umm which develop from these
disorders, […] MS patients or Parkinson’s or whatever,
umm their lifespan is not limited by this illness […].
Neurologist in focus group of neurologists, all in own
practice (fg2ga ll. 1277-1288)
Main category excess
Except for one, all general practitioners and neurologists
in private practice queried felt convinced that they already
offered their MS patients sufficient palliative care (subcat-
egory we already offer PC) when utilizing their broader,
more general definition of palliative care such as “helping
to live better with the illness”.
Depending on how one defines it well, yes. Everything
that no longer heals is palliative, err…, certainly
however that is not meant […] all that we do, is umm
to live better with the illness and somehow accompany,
yes. […] Actually, well we do this already the entire
time, right?
Neurologist in focus group of neurologists, all in own
practice (fg2ga ll. 1390-1412)
The two specialized MS clinic neurologists principally
regard MS patients as palliative care patients since they
suffer from an incurable, chronic disease. These physi-
cians regarded their work at the specialized MS clinic
as palliative work, managing the complex needs of
MS patients (subcategory sufficient structures) and doubtedthat palliative care units were able to meet the special
needs of MS patients due to their lacking the broad
spectrum of therapies currently available which have
been specialized for these patients (subcategory PC
insufficient).
[…] also not on the palliative ward, as no therapies
take place there, there is no physiotherapy, which is of
course very important for treating spasticity, particularly
when they are lying down. That is the point where
palliative care is incompatible with MS.
Interview with clinic neurologist, specialized MS
clinic (galar5 ll. 351-356)
Main category chance
Most of the physicians interviewed regarded palliative
care as an approach aimed at achieving the best available
quality of life for the patient in the time remaining. They
emphasized qualified care, especially with respect to end
of life (subcategory qualified care) and professional pain
treatment (subcategory pain management). In the view
of the neurologists at the specialized MS clinic, palliative
care could aid MS patients with greater financial support as
required for hospital stays long enough to improve certain
symptoms, which often involves weeks or even months
(subcategory financial opportunity).
Discussion
This study specifically documents perceptions of palliative
care of severely affected MS patients and their healthcare
professionals in Germany. The results give first insights
into why severely affected MS patients in Germany only
have sparse access to palliative care in all its forms, includ-
ing hospice care, and aid in generating hypotheses about
how to better approach this situation.
Of all those interviewed, the MS patients had the fewest
associations with palliative care and they had difficulties in
differentiating between hospice and palliative care. One
possible explanation for this lack of awareness might be
that advanced MS patients might have, over time, become
adjusted to living with their disabilities and thus, as be-
comes clear in this study, might not view their condition
as ’terminal’ and in need of palliative care. While in gen-
eral, patients depend on advice from their health profes-
sionals, it is the nurses who are often closest to patients
and of great importance to them [31], and of all the health
professionals interviewed it was the nurses who could at
least imagine what was meant by palliative care. Physicians
and social workers had the broadest spectrum of associa-
tions with palliative care but they predominately focused
on ‘life limitation’ or on the idea that ‘we already offer
palliative care’. However, it was apparent that they were
unsure of what palliative care exactly encompasses, who
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neurological conditions like MS. These physicians and
social workers made no distinction between general and
specialized palliative care and never mentioned these terms.
As patients and nurses are strongly influenced by physi-
cians’ opinions it is no wonder that neither of these groups
are well informed about palliative care.
In fact, the fears surrounding its close association with
death were far more recognized, along with those related
to questioning the capability and expertise of extant care
structures, than were overall opportunities for utilizing
palliative care for MS patients.
In this study one important reason why palliative care
was rejected for MS patients was the overwhelming
opinion that palliative care would be meaningful only
for terminal diseases or for stages typical of various can-
cers. Indeed the illness trajectory of MS and the terminal
care phase are less distinct [32,33] and doubts exist
about whether patients actually truly die from MS [34].
However, death clearly plays a role in MS, as MS pa-
tients could die from their disease or associated compli-
cations [5-7]. As acknowledged by participants in this
study, the handling of death and dying, ostensibly the
core focus of palliative care [32,35], might also play a
role in the management of MS patients [36], so MS and
palliative care are not contradictory, even if regarded in
light of death and dying. We also know that severely af-
fected MS patients are interested in communicating with
their doctors about end of life issues [22] but doctors
hardly ever address this topic with their MS patients al-
though it might be beneficial both for patients and their
families [37].
Another critical point brought up by the participants
in our study was that they predominately associated pal-
liative care with accompanying dying cancer patients. In
contrast to cancer, the end-of-life phase in MS would be
difficult to detect and symptom relief would play a com-
paratively minor role with MS patients. However, severely
affected MS patients are every bit as afflicted as cancer pa-
tients in terms of the characteristics of the symptoms, and
needs assessment of (severely) affected MS patients re-
vealed unmet needs in those areas which could possibly be
met by a palliative concept [8-11,15]. Nevertheless, com-
pared with cancer patients, non-cancer patients, such as
MS patients in Germany, do not have equal access to (spe-
cialized) palliative care and hospice services [32,34,38]; e.g.
between 1993 and 2010 only 2.5% of patients whose deaths
were attributed to MS died in hospice (UK) [39]. Reasons
for less access to these services are that MS patients or
their providers –as in our study– are rarely aware of
such opportunities [34] or an advance care plan is lack-
ing [37,40]. Our study indicates that both patients’ and
health professionals’ fearful attitudes towards palliative
care may also play a role in this.Such fears might potentially emerge from the restricted
and even vague awareness of palliative care exposed in this
study, and these vague ideas about palliative care corres-
pond to the various, partially discordant definitions of
‘palliative care’ and ‘the palliative care patient’, especially
non-cancer palliative care patients [41-43]. A standardized
and consistent definition and care concept of palliative
care offering a reliable understanding of palliative care
philosophy, aims, structures and activities could also aid
in the German MS community discovering and appreciat-
ing previously unforeseen or overlooked opportunities for
MS patients and their caregivers. Fears and doubts in the
context of palliative care could then be resolved, making
renaming ‘palliative care’ ‘supportive’ or ‘comfort care’
[35,42,44,45] unnecessary as well.
In the UK there is now a document available addressing
how palliative care in all its forms could improve care of
patients with long-term neurological conditions: “End of life
care in long term neurological conditions – a framework
for implementation” (NEoLCP) [20]. Pioneering studies in
the UK have also successfully utilized specialized palliative
care services for MS [12-14] or for neurodegenerative
conditions [46].
The response ‘We already offer palliative care’, encap-
sulates a serious concern brought up by physicians in
our study. This reply represents the idea that institution-
alized palliative care might question the capability and
expertise of existing care structures. Such concerns gen-
erally arise in the debate on how specialized outpatient
palliative care could contribute to general (palliative) care
without displacing existing structures [47]. While the pal-
liative care approach alone cannot alleviate the complex
needs of MS patients at large, nor in Germany, as related
to our study, a common care concept for MS patients is
needed which encompasses the expertise of general care
providers as well as of palliative, neuro-rehabilitative and
MS specialists. The MS community has ample knowledge
of the disease, its progression, disease-specific treatment,
needs and complications; including where special multi-
disciplinary rehabilitation programs can often stabilize or
improve patients’ functions. The palliative care commu-
nity is primarily concerned with patient quality of life,
autonomy in end of life decisions, palliation of burden-
some symptoms and accompanying MS patients and their
families through the various in- and outpatient sectors with
assistance from multidisciplinary teams. General care pro-
viders are continuously involved at the ground level and are
familiar with the typical problems of everyday life. These di-
verse skills are complementary and valuable for MS pa-
tients throughout the different stages of the disease. In
contrast to Germany, the UK has already been developing
such a multidisciplinary approach for long-term neuro-
logical conditions like MS, Parkinson’s, motor neuron dis-
eases and Huntington’s disease and this is now spreading.
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different settings a wide range of practice guidance for the
palliative care of neurological patients. Germany must first
reach agreement among representatives of general, MS,
neuro-rehabilitative and palliative care as to who is respon-
sible, when and for what part of an MS patient’s care.
Agreement is needed on when palliative care should be
offered to MS patients, and specifically agreement about
when end of life issues should be considered with these
patients. Indicators have been determined and include
swallowing problems, aspiration pneumonia, recurrent
infections or marked decline in physical status [36]. In
defined tumor entities early integrated palliative care
has been shown to improve quality of life and even lead
to significantly longer survival [48]. It is highly conceiv-
able that MS patients might also profit from such an
early integration of palliative care. If possible treatment
restrictions are already discussed during the early stages
of a disease, then quality of life might improve in later
stages of chronic neurological diseases [37].
How can palliative care be brought to MS patients,
and in our case Germany’s MS patients, on a widespread
basis and meanwhile dispel common fears associated
with it? Initial, low-threshold palliative care contact could
be undertaken by general providers (e.g. GPs, neurolo-
gists), as emphasized by the physicians surveyed for our
study. Ensuring early access to general palliative care re-
quires that appropriate palliative care training be widely
offered for multidisciplinary MS caregivers. In complex
situations specialized in- or outpatient palliative care ser-
vices with essential knowledge about MS might be an
asset in helping to alleviate suffering, as proven in the UK
where specialized outpatient palliative care services for
MS or neurodegenerative conditions have been success-
fully utilized [12-14,46]. The UK studies explicitly make
the crucial delineation that their palliative services were
complementary, and not a substitute for existing services
[12-14,46], both confirming and emphasizing the import-
ance of coexistent providers.
Limitations and strengths of study
As interviews and focus groups could not be conducted
to theoretical saturation, the study results cannot be
generalized. There were barriers prohibiting interviews
with advanced MS patients and similarly, communica-
tion disabilities, cognitive impairments, depression or fa-
tigue made it problematic to conduct some interviews.
Recruiting difficulties with health professionals meant
that the groups interviewed were not equal in number;
physicians (and neurologists among them) represented
the largest group. However, the qualitative approach of
this study made it possible to combine narrative elements
with semi-structured questions. The interview guide was
used flexibly, enabling the interviewees to elaborate theirperspectives. More detail on various attitudes was ob-
tained via this approach. A rigid format of a structured
interview or a questionnaire would not have allowed us to
gather this spectrum of information.
Conclusion
Severely affected MS patients and health professionals in
Germany may have a vague and incomplete perception
of palliative care, leading to misunderstandings, discom-
fort or even fear and rejection. A consistent palliative care
concept with a view towards early integration should be
introduced and made public within the MS community
and among general providers in Germany so as to offer, in
a combined approach, an additional layer of support for
severely affected MS patients in the future.
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